A Systematic Approach to Risk Stratification and Intervention Within a Managed Care Environment Improves Diabetes Outcomes and Patient Satisfaction
A Systematic Approach to Risk Stratification and Intervention Within a Managed Care Environment Improves Diabetes Outcomes and Patient Satisfaction Charles M. Clark, Jr. , MD 1 , James W. Snyder , MD 2 , Robert L. Meek , MS 3 , Linda M. Stutz , RN, MBA 4 and Christopher G. Parkin , MS 5 1 Indiana Un...
Gespeichert in:
Veröffentlicht in: | Diabetes care 2001-06, Vol.24 (6), p.1079-1086 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | A Systematic Approach to Risk Stratification and Intervention Within a Managed Care Environment Improves Diabetes Outcomes
and Patient Satisfaction
Charles M. Clark, Jr. , MD 1 ,
James W. Snyder , MD 2 ,
Robert L. Meek , MS 3 ,
Linda M. Stutz , RN, MBA 4 and
Christopher G. Parkin , MS 5
1 Indiana University, Indianapolis, Indiana;
2 VA Southern Nevada Healthcare System, Las Vegas, Nevada;
3 Roche Diagnostics Corporation;
4 Meszzia Corporation;
5 CGParkin Communications, Indianapolis, Indiana.
Abstract
OBJECTIVE —To determine whether a comprehensive diabetes management program that included risk stratification and social marketing would
improve clinical outcomes and patient satisfaction within a managed care organization (MCO).
RESEARCH DESIGN AND METHODS —The 12-month prospective trial was conducted at primary care clinics within a MCO and involved 370 adults with diabetes.
Measurements included 1 ) the frequency of dilated eye and foot examinations, microalbuminuria assessment, blood pressure measurement, lipid profile,
and HbA 1c measurement; 2 ) changes in blood pressure, lipid levels, and HbA 1c levels; and 3 ) changes in patient satisfaction.
RESULTS —Complete data are reported for the 193 patients who had been enrolled for 12 months; life table analysis is reported for
all patients who remained enrolled at the study’s end as well as for a comparative control group of 623 patients. For the
193 patients for whom 12-month data were available, the number of patients in the low-risk category (HbA 1c 8% at baseline had a change in treatment regimen. Patients at the highest risk for coronary heart disease (LDL >130 mg/dl)
decreased from 25.4% at baseline to 20.2%. Patients with a blood pressure |
---|---|
ISSN: | 0149-5992 1935-5548 |
DOI: | 10.2337/diacare.24.6.1079 |